Author

M. Kodama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1 Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:cryo-EM· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

N. Kurebayashi· 2 shared T. Murayama· 2 shared T. Sakurai· 2 shared A. Miura· 1 shared A. Nordborg· 1 shared A. Toyoda· 1 shared A. Tsutsumi· 1 shared A. V.-P. de Leon· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

N. Kurebayashi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The need for high-resolution gut microbiome characterization to design efficient strategies for sustainable aquaculture production

S. Gupta, A. V.-P. de Leon, M. Kodama, M. Hötzinger, C. G. Clausen, L. Pless, A. Verissimo, B. Stengel, V. Calabuig, R. Kvingedal, S. Skugor, B. Westereng, T. N. Harvey, A. Nordborg, S. Bertilsson, , S. L. La Rosa

This study evaluates microbiota-directed fibers (MDFs) in Atlantic salmon diets, finding negligible effects on gut microbiome and host physiology, but identifying potential endogenous lactic acid bacteria for future MDF strategies.

Communications Biology · Oct 25, 2024Peer-reviewedMicrobiology

Screening for novel RyR2 inhibitors by ER Ca2+ monitoring

M. Takenaka, M. Kodama, T. Murayama, M. Ishigami-Yuasa, S. Mori, R. Ishida, J. Suzuki, K. Kanemaru, M. Sugihara, M. Iino, A. Miura, H. Nishio, S. Morimoto, H. Kagechika, T. Sakurai, N. Kurebayashi

This study identifies three RyR2 inhibitors using an ER Ca2+ monitoring assay, showing they suppress arrhythmogenic Ca2+ waves without affecting normal Ca2+ transients.

bioRxiv · Aug 21, 2023 · PreprintPharmacology & Toxicology

Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory amino acid differences and novel oncoprotein candidates

K. Yahara, V. P. Tuan, H. D. Q. Dung, T. T. Binh, P. H. Tung, T. D. Tri, N. P. M. Thuan, V. V. Khien, T. T. H. Trang, B. H. Phuc, E. Tshibangu-Kabamba, T. Matsumoto, J. Akada, R. Suzuki, T. Okimoto, , Y. Yamaoka

This study uses GWAS to identify genetic variations in H. pylori strains associated with gastric cancer and duodenal ulcers, revealing amino acid differences and novel oncoprotein candidates.

bioRxiv · Mar 15, 2021 · PreprintPhysiology

Molecular basis for gating of cardiac ryanodine receptor: underlying mechanisms for gain- and loss-of function mutations

T. Kobayashi, A. Tsutsumi, N. Kurebayashi, K. Saito, M. Kodama, T. Sakurai, M. Kikkawa, T. Murayama, H. Ogawa

This study identifies two gating mechanisms of RyR2 and shows how mutations affect channel function.

bioRxiv · Nov 30, 2020 · PreprintBiochemistry